SUBSCRIBE
SUBSCRIBE
News   Business   Deals

PhotoCure Announces Plans To De-merge PCI Biotech

November 16, 2007 | 
1 min read
Oslo, Norway, Nov 16, 2007 - (Hugin via ABN Newswire) - De-merger will lead to the subsequent listing of PCI Biotech, Photocure's cancer-focused drug delivery subsidiary, on the Oslo Stock Exchange.
Mergers & acquisitions Europe
MORE ON THIS TOPIC
Blue holographic globe with nodes connected around earth. Concept of global network connection, communication technology, fintech, data exchange, worldwide exchange of information and online banking.
Manufacturing
Merck barred from making subcutaneous Keytruda in 8 European countries
October 8, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Insights
Beyond equity: Why venture debt is reshaping European biotech
October 8, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
Business
Genmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, more
October 7, 2026
 · 
2 min read
 · 
Jef Akst
Merger and acquisition concept. Collage banner with halftone hands reaching out to each other on puzzle background. Handshake, partnership, cooperation, success deal. Modern retro vector illustration
Deals
Shionogi makes $2B rare disease play with IntraBio buy
October 6, 2026
 · 
2 min read
 · 
Tristan Manalac